Indivior Pharmaceuticals, Inc. (INDV)
30.49
+0.02
(+0.07%)
USD |
NASDAQ |
Apr 06, 13:56
Indivior Pharmaceuticals SG&A Expense (TTM) : 635.00M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 317.74M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| CorMedix, Inc. | 99.77M |
| Amicus Therapeutics, Inc. | 383.49M |
| Liquidia Corp. | 157.18M |